>> View All Results for ""
Enter multiple symbols separated by commas
London quotes now available
Market sources tell CNBC Europe that the FDA may deal a blow to Novartis at the end of the month when it publishes findings on Galvus, Novartis' blockbuster pipeline diabetes drug. CNBC's Dan Scott reports from Zurich.